| Literature DB >> 28474303 |
Lydia Renner1, Stefan Kahlert2, Tanja Tesch3, Erik Bannert3, Jana Frahm3, Anikó Barta-Böszörményi1, Jeannette Kluess3, Susanne Kersten3, Peter Schönfeld4, Hermann-Josef Rothkötter1, Sven Dänicke3.
Abstract
The aim of the present study was to examine the role of chronic deoxynivalenol (DON) exposition on the liver morphology and function in combination with pre- and post-hepatic lipopolysaccharide (LPS) stress in young pigs fed for 4 weeks with a DON-contaminated diet (4.59 mg/kg feed). At the end of the experiment, LPS (7.5 μg/kg BW) was administered for 1 h pre-hepatically (Vena portae hepatis) or post-hepatically (Vena jugularis). Liver morphology was macroscopically checked and showed haemorrhage in all LPS groups, significantly higher relative liver weights, accompanied by marked oedema in the gallbladder wall. Histological changes were judged by a modified histology activity index (HAI). Liver HAI score was significantly increased in all LPS groups compared to placebo, primarily due to neutrophil infiltration and haemorrhage. DON feed alone was without effect on the liver HAI. Liver function was characterized by (i) hepatic biochemical markers, (ii) mitochondrial respiration and (iii) Ca2+ accumulation capacity of isolated mitochondria. Clinical chemical parameters characterizing liver function were initially (<3 h) slightly influenced by LPS. After 3 h, bilirubin and alkaline phosphatase were increased significantly, in DON-fed, jugular-infused LPS group. Respiration and Ca2+ accumulation capacity of isolated liver mitochondria was not impaired by chronic DON exposure, acute LPS challenge or combined treatments. DON-contaminated feed did not change macroscopy and histology of the liver, but modified the function under LPS stress. The different function was not linked to modifications of liver mitochondria.Entities:
Keywords: Deoxynivalenol; Lipopolysaccharide; Liver; Mitochondria; Pig
Mesh:
Substances:
Year: 2017 PMID: 28474303 PMCID: PMC5511606 DOI: 10.1007/s12550-017-0279-9
Source DB: PubMed Journal: Mycotoxin Res ISSN: 0178-7888 Impact factor: 3.833
Fig. 1Design of the animal experiment. Barrows (n = 42) received either a control feed (CON) or a DON-contaminated feed (DON; 4.59 mg/kg feed) for 4 weeks; at the end of the experiment, E. coli LPS (7.5 μg/kg BW) or 0.9% saline was infused into jugular (ju) or portal (po) region
Fig. 2a Representative photographs of livers, reflecting the common hepatic macroscopy in each experimental group. Haemorrhages are visible in all LPS-treated groups, but not in groups with saline infusion, irrespective of dietary treatment. b Relative liver weight (g/kg BW) in LPS-treated groups was significantly higher compared to saline-infused counterparts, irrespective of diet. Values are presented as LSMeans (±SEM), and those with uncommon superscripts are significantly different from each other (p < 0.05)
Fig. 3Representative macroscopy and microscopy of gallbladders. a Macroscopic appearance of gallbladder in control animals with physiological wall thickness. b Histological appearance of gallbladder wall in control animals (Masson-Goldner trichrome staining). Epithelium is stained in dark red (right side), myocytes in light red and connective tissue in turquoise. Serosa is visible at the left side of specimen. c Macroscopic appearance of gallbladder in LPS-treated animals with visible thickining of gallbladder wall. d Histological appearance (Masson-Goldner trichrome staining) of gallbladder wall in LPS-treated animals. Subserosa appears markedly enlarged and edematous, muscularis (red structure) just visible on the right side
Fig. 4Histology activity index (HAI) of the liver. Pigs were fed a control (CON) or DON-contaminated diet and infused with LPS or saline (CON) into jugular (ju) or portal (po) region; columns with unlike superscripts differ significantly from each other (Kruskal-Wallis with Dunn’s post-hoc test, p < 0.05)
Effect of DON feeding and pre- or post-hepatic LPS infusion on liver histopathology
| Histopathological parameter | CON CONju-CONpo | CON CONju-LPSpo | CON LPSju-CONpo | DON CONju-CONpo | DON CONju-LPSpo | DON LPSju-CONpo |
|
|---|---|---|---|---|---|---|---|
| Portal (total) | 1.9 (±0.4) a | 3.0 (±0.9) b | 3.1 (±0.6) b | 1.6 (±0.4) a | 3.1 (±0.6) b | 3.3 (±0.7) b | <0.001 |
| Neutrophil | 1.1 (±0.2) a | 1.8 (±0.8) b | 1.7 (±0.4) b | 0.9 (±0.2) a | 1.9 (±0.6) b | 1.8 (±0.5) b | 0.001 |
| Eosinophil | 0.8 (±0.4) a | 1.2 (±0.8) ab | 1.4 (±0.5) b | 0.8 (±0.4) a | 1.3 (±0.3) b | 1.5 (±0.3) b | 0.021 |
| Periportal (total) | 1.6 (±0.6) a | 3.3 (±0.9) b | 3.3 (±0.6) b | 1.3 (±0.4) a | 3.0 (±0.7) b | 3.4 (±0.9) b | <0.001 |
| Neutrophil | 1.1 (±0.5) a | 1.9 (±0.2) b | 2.2 (±0.3) b | 0.8 (±0.3) a | 2.1 (±0.2) b | 2.3 (±0.4) b | <0.001 |
| Eosinophil | 0.5 (±0.2) a | 1.3 (±0.9) b | 1.1 (±0.4) b | 0.5 (±0.4) a | 0.9 (±0.5) ab | 1.2 (±0.9) ab | 0.033 |
| Acinar (total) | 2.3 (±0.5) a | 3.8 (±0.9) b | 3.6 (±0.9) b | 1.9 (±0.7) a | 3.6 (±0.8) b | 3.8 (±1.1) b | <0.001 |
| Neutrophil | 1.1 (±0.2) a | 2.0 (±0.6) b | 1.8 (±0.5) b | 1.0 (±0.0) a | 2.1 (±0.2) b | 1.8 (±0.4) b | <0.001 |
| Eosinophil | 1.1 (±0.4) | 1.8 (±0.9) | 1.8 (±0.8) | 0.9 (±0.7) | 1.6 (±0.8) | 2.0 (±0.8) | 0.065 |
| Neutrophil (total) | 3.3 (±0.5) a | 5.8 (±1.4) b | 5.7 (±0.9) b | 2.6 (±0.4) a | 6.0 (±0.8) b | 5.8 (±1.1) b | <0.001 |
| Eosinophil (total) | 2.4 (±0.7) ab | 4.3 (±2.3) bc | 4.3 (±1.1) c | 2.1 (±1.1) a | 3.8 (±1.4) bc | 4.7 (±2.0) c | 0.008 |
| Inflammation (total) | 5.7 (±0.9) a | 10.0 (±2.4) b | 10.0 (±1.5) b | 4.8 (±1.0) a | 9.8 (±1.6) b | 10.5 (±2.5) b | <0.001 |
| Confluent necrosis | 1.1 (±0.8) | 0.3 (±0.5) | 0.5 (±0.9) | 0.5 (±0.8) | 0.9 (±0.8) | 0.5 (±0.8) | 0.35 |
| Focal necrosis | 1.0 (±0.3) | 0.5 (±0.5) | 1.0 (±1.0) | 1.1 (±0.5) | 0.6 (±0.4) | 0.8 (±0.4) | 0.29 |
| Haemorrhage | 0.3 (±0.4) a | 3.7 (±1.9) b | 2.8 (±1.7) b | 0.2 (±0.4) a | 2.9 (±1.9) b | 4.4 (±0.6) b | <0.001 |
| Cumulative HAI | 8.1 (±1.88) a | 14.5 (±3.08) b | 14.3 (±2.35) b | 6.6 (±1.46) a | 14.2 (±3.78) b | 16.2 (±3.08) b | <0.001 |
Individual histological parameters, the sum of different parameters regarding inflammation and the cumulative histology activity index (HAI) are presented as means (±SD). The p value of the fixed factor “group” is also provided. Different lowercase letters in a row indicate significance between groups, p < 0.05 (Dunn’s post-hoc test)
CON control feed, DON DON feed, CON saline infusion jugular catheter, LPS LPS infusion jugular catheter, CON saline infusion portal catheter, LPS infusion portal catheter
Effect of dietary mycotoxin and subsequent immune challenge on clinical chemical parameters (LSMeans)
| Group |
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| CON_ CONju-CONpo | CON_ CONju-LPSpo | CON_ LPSju-CONpo | DON_ CONju-CONpo | DON_ CONju-LPSpo | DON_ LPSju-CONpo | Group | Sitea | Time | g*s*t | |
| Time | AST (<35 IU/L) | |||||||||
| −30 | 32.2 | 33.0 | 32.6 | 32.1 | 32.5 | 31.0 | 0.18 | 0.97 | <0.001 | 0.03 |
| 60 | 31.8 | 30.5 | 31.5 | 33.1 | 32.9 | 29.7 | ||||
| 120 | 28.7 | 31.9 | 31.3 | 31.1 | 30.6 | 31.9 | ||||
| 180 | 28.0 | 39.2 | 38.2 | 33.2 | 38.1 | 39.1 | ||||
| PSEM | 1.1 | |||||||||
| γGT (<45 IU/L) | ||||||||||
| −30 | 30.6 | 30.6 | 30.6 | 30.3 | 30.9 | 30.3 | <0.001 | 0.36 | 0.002 | 0.002 |
| 60 | 30.0 | 33.2 | 33.4 | 27.5 | 36.9 | 35.1 | ||||
| 120 | 29.0 | 31.9 | 36.8 | 27.9 | 35.0 | 36.2 | ||||
| 180 | 27.4 | 31.7 | 38.5 | 26.6 | 34.5 | 32.9 | ||||
| PSEM | 0.9 | |||||||||
| ALP (<170 IU/L) | ||||||||||
| −30 | 134.2 | 134.3 | 132.0 | 129.7 | 134.6 | 132.7 | 0.01 | 0.93 | <0.001 | 0.03 |
| 60 | 135.3 | 141.4 | 146.8 | 135.2 | 143.2 | 160.2 | ||||
| 120 | 132.7 | 140.6 | 135.7 | 124.5 | 122.4 | 152.6 | ||||
| 180 | 110.0 | 174.4 | 180.1 | 122.0 | 146.0 | 236.7 | ||||
| PSEM | 8.4 | |||||||||
| ALB (18–31 g/L) | ||||||||||
| −30 | 37.8 | 38.0 | 38.0 | 37.5 | 37.8 | 37.7 | 0.28 | 0.39 | <0.001 | 0.26 |
| 60 | 35.9 | 36.4 | 37.3 | 35.6 | 37.0 | 35.3 | ||||
| 120 | 35.3 | 33.7 | 34.6 | 35.6 | 33.0 | 33.5 | ||||
| 180 | 34.2 | 32.5 | 34.6 | 35.1 | 31.6 | 31.3 | ||||
| PSEM | 0.6 | |||||||||
| Total protein (55–86 g/L) | ||||||||||
| −30 | 52.9 | 53.1 | 53.2 | 52.7 | 53.0 | 53.0 | 0.03 | 0.50 | <0.001 | <0.001 |
| 60 | 50.0 | 50.8 | 52.1 | 49.6 | 51.2 | 48.7 | ||||
| 120 | 49.6 | 45.4 | 47.8 | 48.4 | 44.7 | 45.3 | ||||
| 180 | 48.6 | 43.9 | 46.5 | 48.9 | 44.2 | 42.1 | ||||
| PSEM | 0.701 | |||||||||
Physiological reference values are provided in brackets (Kraft and Dürr 2014)
AST aspartate aminotransferase (IU/L), γGT gamma glutamyl transferase (IU/L), ALP alkaline phosphatase (IU/L), ALB albumin (g/L), total protein (g/L), CON control feed, DON DON feed, CON saline infusion jugular catheter, LPS LPS infusion jugular catheter, CON saline infusion portal catheter, LPS portal infusion portal catheter, PSEM pooled standard error of the mean
aAs there was no difference between sampling sites (V. jugularis ext. and V. portae hepatis), mean value of jugular and portal samples was calculated and is shown in the table
Fig. 5Bilirubin concentrations in peripheral and portal blood. Effect of chronic enteral Fusarium toxin deoxynivalenol (DON) exposure and pre- or post-hepatic E. coli LPS infusion on total bilirubin concentrations in V. jugularis interna and portal V. portae hepatis. Bilirubin was significantly increased in LPS groups 180 min after start of infusion compared to placebo-infused groups. Additionally, DON_LPS -CON had significantly higher concentrations compared to their control-fed counterparts CON_LPS -CON , whereas this was not the case for portal-infused LPS groups. Reference value of total bilirubin (Kraft and Dürr 2014): ≤0.25 mg/dL in blood. Main effects (F test) were calculated at group (g) pgroup = 0.008; infusion site (s) psite = 0.371; time (t) ptime < 0.001. Interaction pg × s × < 0.001; different letters indicate significant differences between groups (p < 0.05, post-hoc t test)
Fig. 6Effect of DON and subsequent LPS-infusion on states III and IV respirations of porcine liver mitochondria. Liver mitochondria were isolated from animals fed with control (CON)- or DON (DON)-contaminated diet for 4 weeks and subsequently infused for 1 h with either LPS (7.5 μg/kg BW) via a jugular or portal catheter (LPSju or LPSpo) or NaCl after sacrifice. In isolated liver, respiration was estimated using malate/glutamate as substrates in presence (state III) and absence (state IV) of ADP. Mean values of state III and state IV respiration of 6–7 animals per group (n between bars) were analysed by ANOVA. No statistically significant differences were found between groups ± SEM
Effect of DON-contaminated feed and a subsequent LPS challenge on Ca2+ retention capacity (CRC) of porcine liver mitochondria
| Accumulated Ca2+ (nmol/mg mitochondrial protein) | CON_ CONju-CONpo | CON_ CONjuLPSpo | CON_ LPSju-CONpo | DON_ CONju-CONpo | DON_ CONju-LPSpo | DON_ LPSju-CONpo |
|---|---|---|---|---|---|---|
| 1 mM Pi | 130 ± 22 | 113 ± 13 | 133 ± 15 | 105 ± 14 | 129 ± 16 | 126 ± 10 |
| 1 mM Pi + CsA | 908 ± 56 | 850 ± 58 | 964 ± 67 | 817 ± 42 | 921 ± 44 | 870 ± 68 |
| 10 mM Pi | 90 ± 11 | 70 ± 9 | 94 ± 20 | 75 ± 13 | 83 ± 11 | 88 ± 18 |
| 10 mM Pi + CsA | 850 ± 44 | 792 ± 90 | 829 ± 66 | 783 ± 54 | 833 ± 55 | 870 ± 78 |
Mean values (±SEM) of each experimental setup (1, 10 mM Pi, with or without CsA) of 6–7 animals per group were analysed by ANOVA. No statistically significant differences were found between experimental groups
CON control feed, DON DON feed, CON saline infusion jugular catheter, LPS LPS infusion jugular catheter, CON saline infusion portal catheter, LPS portal infusion portal catheter, P inorganic phosphate, CsA cyclosporine A